Mood and Decision-making in Methamphetamine Use Disorder

Methamphetamine Abuse Clinical Trial

— MDM-MUD  

Official title:

Modulating Explore-exploit Biases by Improving Mood in Adults With Methamphetamine Use Disorder

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06410196
• Other study ID #: 2024-002
• Secondary ID: P20GM121312
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2024
• Est. completion date: July 2026

Study information

• Verified date: May 2024
• Source: Laureate Institute for Brain Research, Inc.
• Contact: Maëlle CM Gueguen, PhD
• Phone: 918-502-5155
• Email: mgueguen[@]laureateinstitute.org
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this project, the investigators examine behavior and associated brain activity during explore-exploit decision-making tasks performed pre- and post-modulation of affective state using autobiographical memory recall. The investigators hypothesize that a positive memory recall will reduce negative affective state, reduce explore-exploit biases and normalize the associated brain activity. The investigators propose a randomized double-blind, sham-controlled trial of positive autobiographical memory recall with 80 adults (n=40 per arm) with methamphetamine use disorder (MUD) currently involved in abstinence only treatment centers.

Description:

The growing epidemic of methamphetamine use disorder (MUD) is a significant burden on public health with surging overdose deaths, high likelihood of relapse, and current lack of approved medication to treat the disorder. When it comes to decision-making, individuals with MUD often prioritize drug over non-drug rewards despite negative life consequences; in addition, they may not sufficiently "explore" all available choices to "exploit" the best one (in other words, make the optimal choice leading to positive consequences). Therefore, the "explore-exploit" trade-off is often dysfunctional in MUD. Decision-making imbalances in the explore-exploit trade-off may extend well into abstinence, a period marked by a negative affective state (low mood, high depression and anxiety, withdrawal), which in turn triggers heightened craving and subsequent drug use urges. The insula, anterior cingulate cortex and striatum are crucial brain regions involved in explore-exploit behaviors and affective state signaling that have also been linked to drug reward processing in MUD. We propose that reducing negative affective state (improving mood) could help normalize explore-exploit behaviors and the response of these brain areas in individuals currently abstinent from methamphetamine and other drugs. This project will use a non-drug-related autobiographical memory recall to improve the mood of individuals with MUD and measure whether it normalizes non-drug decision-making, using a functional magnetic resonance imaging-based 3-arm bandit task and a behavioral contextual reinforcement learning task. A mixed experimental design in n=80 (72 completers, assuming 10% attrition) allows the identification of a between-subjects effect of positive (n=40, 36 completers) vs. neutral (n=40, 36 completers) mood modulation and assess the within-subject impact on explore-exploit behaviors pre- versus post-mood modulation. Mood groups will be compared on positive and negative affect, and behavioral/brain responses to reward valuation, outcomes and learning rates.

The overarching goal is to establish that improving mood in individuals with MUD can reduce their negative affective state, normalize outcome sensitivity in key brain regions and associated learning, and reduce the influence of drug rewards on the valuation of non-drug rewards. This approach of this proposal embodies the goals of the NIH RDoC Initiative and the NeuroMAP Center by identifying an actionable disease-modifying target (mood) and studying its effect on the cognitive and neural dysfunction underlying a specific cognitive process (explore-exploit behaviors) relevant to MUD, and possibly other related neuropsychiatric disorders. By targeting the intertwined mechanisms between negative affect and explore-exploit biases, innovative, effective intervention strategies for MUD may be unveiled, addressing a critical public health challenge.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 80
• Est. completion date: July 2026
• Est. primary completion date: July 2026
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Adults 18-65 years old

• English proficiency as evaluated by language ability during screening

• Past-year diagnosis of DSM-5 methamphetamine use disorder (MUD) confirmed by the MINI

• Actively enrolled in treatment for substance use disorder.

Exclusion Criteria:

• Severe traumatic brain injury (as indicated by a score =3 on the Tulsa Head Injury Screen

• Any medical condition interfering with the participation in the study as determined by medical screening

• DSM-5 diagnosis of psychotic disorders, bipolar I disorder, or major depressive disorder with psychosis

• fMRI contraindications as listed on the MR environment screening form

• Positive breathalyzer for alcohol

• Positive urine drug screening, except for cannabis or prescribed benzodiazepines, as indicated in the medical screening

• Evidence of inability to comply with study procedures based on judgement of the experimenter.

Related Conditions & MeSH terms

• Methamphetamine Abuse

Intervention

Behavioral:
• Mood modulation
Autobiographical memory recall designed to modulate mood and affective state by reminiscing about personal life events

Locations

Country	Name	City	State
United States	Laureate Institute for Brain Research	Tulsa	Oklahoma

Sponsors (2)

Lead Sponsor	Collaborator
Laureate Institute for Brain Research, Inc.	National Institute of General Medical Sciences (NIGMS)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Current affective state	Use of PANAS-PA and PANAS-NA questionnaires to measure positive and negative affect respectively (scale range: 0=low; 60=high; low mood is defined as low positive and/or high negative affect)	Change from pre-intervention (baseline) to post-intervention (90min later) on study day 1
Primary	Learning rates	Computational modeling is used to compute how fast (learning rate) participants update their choice strategy following appetitive and aversive outcomes during 3-arm bandit task	Change from pre-intervention (baseline) to post-intervention (30min later) on study day 1
Primary	Response to punishment in insular cortex	BOLD signal is used to measure the activity in the insula as a predefined region of interest (ROI), using Brainnetome atlas, following the delivery of aversive outcomes during 3-arm bandit task	Change from pre-intervention (baseline) to post-intervention (30min later) on study day 1
Primary	Correct choice rate of mid-value option in contexts 1 (M1) and 2 (M2) during the testing phase	Proportion of trials for which the mid-value option is correctly chosen when paired against a high- or low-value option during contextual RL task	Change from pre-intervention (baseline) to post-intervention (60min later) on study day 1
Primary	?BIC for absolute vs. relative value coding	Difference in model-fitting between the absolute and intrinsically enhanced or range adaptive (relative) models as measured by Bayesian Information Criterion (?BIC) during contextual RL task	Change from pre-intervention (baseline) to post-intervention (60min later) on study day 1
Secondary	Response to punishment in anterior cingulate cortex (ACC)	BOLD signal is used to measure the activity in the ACC as a predefined ROI, using Brainnetome atlas, following the delivery of aversive outcomes during 3-arm bandit task	Change from pre-intervention (baseline) to post-intervention (30min later) on study day 1
Secondary	Response to punishment in striatum	BOLD signal is used to measure the activity in the striatum as a predefined ROI, using Brainnetome atlas, following the delivery of aversive outcomes during 3-arm bandit task	Change from pre-intervention (baseline) to post-intervention (30min later) on study day 1
Secondary	Influence of abstinence duration on value coding	Across participants, correlation of number of days since last use of amphetamine with ?BIC during contextual RL task	Change from pre-intervention (baseline) to post-intervention (60min later) on study day 1
Secondary	Influence of craving on value coding	Across participants, correlation of intensity of craving for amphetamine with ?BIC during contextual RL task	Change from pre-intervention (baseline) to post-intervention (60min later) on study day 1
Secondary	Influence of withdrawal on value coding	Across participants, correlation of intensity of withdrawal for amphetamine with ?BIC during contextual RL task	Change from pre-intervention (baseline) to post-intervention (60min later) on study day 1